Characteristics and Reporting of Number Needed to Treat, Number Needed to Harm, and Absolute Risk Reduction in Controlled Clinical Trials, 2001-2019

被引：12

作者：

Elliott, Marissa H. ^{[1
]}

Skydel, Joshua J. ^{[2
]}

Dhruva, Sanket S. ^{[3
]}

Ross, Joseph S. ^{[4
]}

Wallach, Joshua D. ^{[5
]}

机构：

[1] Yale Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA

[2] Tufts Univ, Sch Med, Boston, MA 02111 USA

[3] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA USA

[4] Yale Sch Med, Dept Internal Med, New Haven, CT USA

[5] Yale Sch Publ Hlth, Dept Environm Hlth Sci, 60 Coll St,4th Floor,Room 411, New Haven, CT 06510 USA

来源：

JAMA INTERNAL MEDICINE | 2021年 / 181卷 / 02期

关键词：

D O I：

10.1001/jamainternmed.2020.4799

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This cross-sectional study assesses the trends and characteristics of absolute measure reporting in highly cited medical journals from 2001 to 2019.

引用

页码：282 / 284

页数：3

共 50 条

[21] Confidence intervals for the number needed to treat - Absolute risk reduction is less likely to be misunderstood [J].

Newcombe, RG .

BRITISH MEDICAL JOURNAL, 1999, 318 (7200) :1765-1765

[22] Lumateperone in Pooled Late-Phase Schizophrenia Trials: Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed [J].

Citrome, Leslie ;

Durgam, Suresh ;

Edwards, John B. ;

Davis, Robert E. .

CNS SPECTRUMS, 2023, 28 (02) :244-244

[23] Quantitative Benefit-Risk Assessment of Rosiglitazone: Number Needed to Treat, Number Needed to Harm and Likelihood to be Helped or Harmed [J].

Mendes, D. ;

Alves, C. ;

Batel-Marques, F. .

DRUG SAFETY, 2014, 37 (10) :859-859

[24] Benefit-Risk Assessment Using Number Needed to Treat and Number Needed to Harm for Time-to-Event Endpoints [J].

Ke, Chunlei ;

Jiang, Qi .

STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2016, 8 (04) :379-385

[25] Reporting of number needed to treat and its difficulties [J].

Goroubi, Tarzam ;

Jafarian, Sirous ;

Firooz, Alireza .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (04) :729-730

[26] The number remaining at risk: An adjunct to the number needed to treat [J].

Massel, D ;

Cruickshank, MK .

CANADIAN JOURNAL OF CARDIOLOGY, 2002, 18 (03) :254-258

[27] Relative and absolute risk reduction and number needed to treat (RRR, ARR and NNT): A comparison of osteoporosis fracture trials. [J].

Mindeholm, L. ;

Olson, M. ;

Eriksen, E. F. ;

Johnell, O. ;

Kanis, J. A. .

JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 :S422-S423

[28] Evidence-based medicine (EBM) in practice: Applying number needed to treat and number needed to harm [J].

Sierra, F .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (08) :1661-1663

[29] DARIDOREXANT IN PATIENTS WITH INSOMNIA DISORDER: NUMBER NEEDED TO TREAT, NUMBER NEEDED TO HARM & LIKELIHOOD TO BE HELPED OR HARMED [J].

Chalet, Francois-Xavier ;

Luyet, Pierre-Philippe ;

Rabasa, Cristina ;

Vaillant, Cedric ;

Saskin, Paul ;

Ahuja, Ajay ;

Citrome, Leslie .

SLEEP, 2023, 46 :A155-A155

[30] Cariprazine for bipolar depression: What is the number needed to treat, number needed to harm and likelihood to be helped or harmed? [J].

Citrome, Leslie .

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2019, 73 (10)

← 1 2 3 4 5 →